Quick Answer
Centessa Pharmaceuticals plc reported Long-Term Debt of $110.09 million for fiscal year 2025.
Centessa Pharmaceuticals plc Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $110.09M | +1.1% |
| 2024 | $108.94M | +43.9% |
| 2023 | $75.70M | +8.5% |
| 2022 | $69.80M | -7.8% |
| 2021 | $75.70M | — |
| 2020 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $109.82M | +45.1% | +0.2% |
| June 30, 2025 | $109.55M | +43.2% | +0.3% |
| March 31, 2025 | $109.25M | +42.3% | +0.3% |
| December 31, 2024 | $108.94M | +43.9% | +43.9% |
| September 30, 2024 | $75.70M | +2.3% | -1.0% |
| June 30, 2024 | $76.50M | +4.4% | -0.4% |
| March 31, 2024 | $76.80M | +7.3% | +1.5% |
| December 31, 2023 | $75.70M | +8.5% | +2.3% |
- Centessa Pharmaceuticals plc showed an increase of +1.1% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from Centessa Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: